Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 3Phase 1/2 2

Status

Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 6Lymphoma, B-Cell 5Recurrence 4Burkitt Lymphoma 4Neoplasm, Residual 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Multiple Myeloma 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Glioma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Simpson-Golabi-Behmel syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Platinum-Resistant Ovarian Carcinoma 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 41fludarabine 31Dexamethasone 27venetoclax 24Cytarabine 22Rituximab 16pembrolizumab 15fludarabine phosphate 14Filgrastim 12Etoposide 12Lenalidomide 11Vincristine 10Gemcitabine 10Azacitidine 10pomalidomide 9Interleukin-2 9Granulocyte Colony-Stimulating Factor 9Doxorubicin 9Calcium Dobesilate 9carfilzomib 8Topotecan 8Nivolumab 8Methotrexate 8Everolimus 8Decitabine 8Bortezomib 8Melphalan 7Cisplatin 7Vorinostat 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Recurrence × Immunotherapy, Adoptive × Clear all
NCT06649227 2025-12-05

CARLA-M19

University Hospital, Lille

Phase 1 Recruiting
5 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT06647329 2024-10-17

CAR-T Therapy

Zhengzhou University

Phase 1 Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Recurrence

NCT03423992 2021-06-15

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Xuanwu Hospital, Beijing

Phase 1 Unknown
100 enrolled
CNS

Glioma, Recurrence

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Henan Cancer Hospital

Phase 1 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡